Epidemiology of viral hepatitis among Iranian population - A viral marker study

Homayoon Farzadegan, M. Shamszad, K. Noori-Arya

Research output: Contribution to journalArticle

Abstract

Our studies revealed that the incidence of viral hepatitis in Iran is more common than in the western countries. Although the incidence of hepatitis type A in the region is not thoroughly investigated, our first report on this disease in our region reveals an almost complete immunity among adults after 30 years of age. The incidence of HBsAg among our voluntary blood donors is 3.5%. If it is assumed that the incidence rate in the whole country is also 3.5%. If it is assumed that the incidence rate in the whole country is also 3.5%, then it is possible that there are one million HBsAg carriers among 35 million Iranians. These carriers constitute a major health problem in Iran. There is a good possibility that the HBsAg incidence rate in the other countries of the region is similarly high. Therefore it is highly recommended that control and preventive measures such as third generation HB testing of donated blood and blood products become mandatory. All HBsAg-positive donors should be interviewed and informed that their blood contains an infectious agent and this must be carefully considered at the times of bleeding. Other high risk groups such as hemodialysis patients and staff and hemophiliacs should also be investigated as possible candidates for HB vaccination.

Original languageEnglish (US)
Pages (from-to)144-148
Number of pages5
JournalAnnals of the Academy of Medicine Singapore
Volume9
Issue number2
StatePublished - 1980
Externally publishedYes

Fingerprint

Hepatitis
Hepatitis B Surface Antigens
Epidemiology
Biomarkers
Incidence
Population
Iran
Bleeding Time
Hepatitis A
Blood Donors
Renal Dialysis
Immunity
Vaccination
Cohort Studies
Tissue Donors
Health

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Epidemiology of viral hepatitis among Iranian population - A viral marker study. / Farzadegan, Homayoon; Shamszad, M.; Noori-Arya, K.

In: Annals of the Academy of Medicine Singapore, Vol. 9, No. 2, 1980, p. 144-148.

Research output: Contribution to journalArticle

@article{e7302a21a4224d568cc2095f64a70b88,
title = "Epidemiology of viral hepatitis among Iranian population - A viral marker study",
abstract = "Our studies revealed that the incidence of viral hepatitis in Iran is more common than in the western countries. Although the incidence of hepatitis type A in the region is not thoroughly investigated, our first report on this disease in our region reveals an almost complete immunity among adults after 30 years of age. The incidence of HBsAg among our voluntary blood donors is 3.5{\%}. If it is assumed that the incidence rate in the whole country is also 3.5{\%}. If it is assumed that the incidence rate in the whole country is also 3.5{\%}, then it is possible that there are one million HBsAg carriers among 35 million Iranians. These carriers constitute a major health problem in Iran. There is a good possibility that the HBsAg incidence rate in the other countries of the region is similarly high. Therefore it is highly recommended that control and preventive measures such as third generation HB testing of donated blood and blood products become mandatory. All HBsAg-positive donors should be interviewed and informed that their blood contains an infectious agent and this must be carefully considered at the times of bleeding. Other high risk groups such as hemodialysis patients and staff and hemophiliacs should also be investigated as possible candidates for HB vaccination.",
author = "Homayoon Farzadegan and M. Shamszad and K. Noori-Arya",
year = "1980",
language = "English (US)",
volume = "9",
pages = "144--148",
journal = "Annals of the Academy of Medicine, Singapore",
issn = "0304-4602",
publisher = "Academy of Medicine Singapore",
number = "2",

}

TY - JOUR

T1 - Epidemiology of viral hepatitis among Iranian population - A viral marker study

AU - Farzadegan, Homayoon

AU - Shamszad, M.

AU - Noori-Arya, K.

PY - 1980

Y1 - 1980

N2 - Our studies revealed that the incidence of viral hepatitis in Iran is more common than in the western countries. Although the incidence of hepatitis type A in the region is not thoroughly investigated, our first report on this disease in our region reveals an almost complete immunity among adults after 30 years of age. The incidence of HBsAg among our voluntary blood donors is 3.5%. If it is assumed that the incidence rate in the whole country is also 3.5%. If it is assumed that the incidence rate in the whole country is also 3.5%, then it is possible that there are one million HBsAg carriers among 35 million Iranians. These carriers constitute a major health problem in Iran. There is a good possibility that the HBsAg incidence rate in the other countries of the region is similarly high. Therefore it is highly recommended that control and preventive measures such as third generation HB testing of donated blood and blood products become mandatory. All HBsAg-positive donors should be interviewed and informed that their blood contains an infectious agent and this must be carefully considered at the times of bleeding. Other high risk groups such as hemodialysis patients and staff and hemophiliacs should also be investigated as possible candidates for HB vaccination.

AB - Our studies revealed that the incidence of viral hepatitis in Iran is more common than in the western countries. Although the incidence of hepatitis type A in the region is not thoroughly investigated, our first report on this disease in our region reveals an almost complete immunity among adults after 30 years of age. The incidence of HBsAg among our voluntary blood donors is 3.5%. If it is assumed that the incidence rate in the whole country is also 3.5%. If it is assumed that the incidence rate in the whole country is also 3.5%, then it is possible that there are one million HBsAg carriers among 35 million Iranians. These carriers constitute a major health problem in Iran. There is a good possibility that the HBsAg incidence rate in the other countries of the region is similarly high. Therefore it is highly recommended that control and preventive measures such as third generation HB testing of donated blood and blood products become mandatory. All HBsAg-positive donors should be interviewed and informed that their blood contains an infectious agent and this must be carefully considered at the times of bleeding. Other high risk groups such as hemodialysis patients and staff and hemophiliacs should also be investigated as possible candidates for HB vaccination.

UR - http://www.scopus.com/inward/record.url?scp=0019155483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019155483&partnerID=8YFLogxK

M3 - Article

C2 - 7425524

AN - SCOPUS:0019155483

VL - 9

SP - 144

EP - 148

JO - Annals of the Academy of Medicine, Singapore

JF - Annals of the Academy of Medicine, Singapore

SN - 0304-4602

IS - 2

ER -